NEO/NVON (NEO/NVON)

Cboe Canada: NEO/NVON · CAD

CA$4.22

+0.09 (+2.2%)· Recorded snapshot

Market cap	241.2B
Revenue (ttm)	71.5B
Net income (ttm)	25.3B
EPS (ttm)	CA$0.42
P/E (trailing)	9.9x
P/E (forward)	11.5x
Dividend	CA$0.04 (0.95%)
Volume	56,758
Beta	0.38

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 71.5B
Net income (ttm): 25.3B
EPS (ttm): CA$0.42
P/E (trailing): 9.9x
P/E (forward): 11.5x
Market cap: 241.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E11.5

P25 n/aP50 n/aP75 n/a

Trailing P/E9.9

P25 n/aP50 n/aP75 n/a

ROE59.8

P25 n/aP50 n/aP75 n/a

ROIC39.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NEO/NVON indicators

Market & fundamental data

Available fields

234

Groups with data

Currency

DKK

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Denmark
Country code	CA
Earnings date	2026-11-04
Employees	66,700
Employees change	-7,844
Employees growth	-10.14%
Enterprise value	CAD 261.2B
Exchange	Cboe Canada
Financial currency	DKK
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1923
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CA67010H1091
Last earnings date	2026-08-05
Last refreshed	2026-10-29
Market cap	CAD 241.2B
Next earnings date	2026-11-04
Price	CAD 4.22
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	neo/NVON
Website	https://www.novonordisk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	25.52x
Average P/E ratio (3Y)	26.67x
Average P/E ratio (5Y)	30.16x
Earnings yield	10.05%
EV/Earnings	10.13x
EV/EBIT	7.58x
EV/EBITDA	6.98x
EV/FCF	15.56x
EV/Sales	3.71x
FCF / EV yield	6.43%
FCF yield	6.97%
Forward P/E	11.47x
Graham number	2.89034
Graham upside	-30.02%
Lynch fair value	CAD 9.41
Lynch upside	127.85%
P/(FCF - SBC) ratio	14.62x
P/(OCF - SBC) ratio	8.34x
P/B ratio	4.92x
P/E ratio	9.95x
P/FCF ratio	14.35x
P/OCF ratio	8.25x
P/S ratio	3.3x
Price / tangible book value	10.97x
Price/EBITDA ratio	6.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	48.99%
EBITDA margin	52.72%
Effective tax rate	21.72%
FCF margin	23.96%
Gross margin	81.99%
Operating margin	48.99%
Pretax margin	45.15%
Profit margin	35.35%
Profit per employee	CAD 378,845
Profitable quarters	164
Profitable years	41
Revenue per employee	CAD 1.1M
ROA	18.73%
ROA (5Y)	21.35%
ROCE	45.35%
ROE	59.82%
ROE (5Y)	74.56%
ROIC	39.22%
ROIC (5Y)	68.16%
SBC / revenue	0.44%
Tax / revenue	9.81%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	4.98%
EPS growth (Q)	-20.61%
EPS growth (QoQ)	-56.63%
EPS growth 10Y	14.01%
EPS growth 3Y	20.74%
EPS growth 5Y	22.33%
EPS growth years	31
FCF growth	14.3%
FCF growth (Q)	56.84%
FCF growth (QoQ)	232.92%
FCF growth 3Y	2.24%
FCF growth 5Y	9.51%
Gross profit growth	2.76%
Gross profit growth (Q)	-4.1%
Gross profit growth 3Y	16.73%
Gross profit growth 5Y	20.17%
Net income growth	4.84%
Net income growth (Q)	-20.81%
Net income growth (QoQ)	-56.77%
Net income growth 3Y	20.09%
Net income growth 5Y	21.29%
Net income growth years	38
OCF growth	7.52%
OCF growth (Q)	32.14%
OCF growth (QoQ)	129.19%
OCF growth 10Y	11.56%
OCF growth 3Y	13.7%
OCF growth 5Y	19.47%
Operating income growth	9.29%
Operating income growth (Q)	-0.18%
Operating income growth 3Y	22.91%
Operating income growth 5Y	24.43%
Revenue growth	5.61%
Revenue growth (Q)	2.12%
Revenue growth (QoQ)	-18.94%
Revenue growth 10Y	11.56%
Revenue growth 3Y	17.84%
Revenue growth 5Y	20.45%
Revenue growth quarters	2
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -12.2B
Depreciation and amortization	CAD 2.6B
EBIT	CAD 35B
EBITDA	CAD 37.7B
EPS	CAD 0.42
Financing cash flow	CAD -4.8B
Free cash flow	CAD 16.5B
Free cash flow minus SBC	CAD 16.1B
Gross profit	CAD 58.6B
Income taxes	CAD 7B
Investing cash flow	CAD -18.1B
Net borrowing	CAD 7.6B
Net cash flow	CAD 5.7B
Net income	CAD 25.3B
Operating cash flow minus SBC	CAD 28.3B
Operating income	CAD 35B
Revenue	CAD 71.5B
Stock-based compensation	CAD 311.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.21
Book value per share	CAD 10.84
Debt / EBITDA	0.8
Debt / equity	0.63
Debt / FCF	1.85
Goodwill	CAD 4.1B
Interest coverage	1,566.84
Long-term assets	CAD 85.6B
Long-term liabilities	CAD 31.2B
Net cash (debt)	CAD -20.6B
Net cash / market cap	-8.75%
Net debt / EBITDA	0.55
Net debt / equity	0.43
Net debt / FCF	1.25
Piotroski F-Score	5
Property, plant and equipment	CAD 48.3B
Shareholders' equity	CAD 48B
Tangible book value	CAD 21.5B
Tangible book value per share	CAD 4.86
Total assets	CAD 129.1B
Total cash	CAD 9.8B
Total debt	CAD 30.4B
Total liabilities	CAD 81.1B
WACC	5.64%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.61
Current assets	CAD 43.5B
Current liabilities	CAD 49.9B
Current ratio	0.87
Inventory turnover	1.22
Net working capital	CAD -12.4B
Quick ratio	0.64
Working capital	CAD -6.6B
Working capital turnover	-1.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.14%
Dividend growth	23.45%
Dividend growth years	0
Dividend payment years	2
Dividend payout frequency	Semi-Annual
Dividend per share	CAD 0.04
Dividend yield	0.95%
Ex-dividend date	2026-08-17
Last dividend	CAD 0.06
Payout ratio	44.64%
Shareholder yield	1.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 4.58
1D price change	2.18%
1M price change	0.72%
1M total return	0.72%
1W price change	-1.18%
1W total return	-1.18%
1Y price change	-23.77%
1Y return CAGR	-23.78%
1Y total return	-23.77%
20-day SMA	CAD 4.15
200-day SMA	CAD 4.65
3M price change	-22.49%
3M total return	-22.49%
50-day SMA	CAD 4.42
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 6.63
52-week high date	2026-01-23
52-week low	CAD 3.70
52-week low date	2026-03-30
6M price change	-2.11%
6M total return	-2.11%
All-time high	CAD 10.80
All-time high date	2025-02-25
All-time low	CAD 3.70
All-time low date	2026-03-30
Average true range (ATR)	CAD 0.09
Average volume	34.8K
Beta (5Y)	0.38
Change from 52-week high	-36.35%
Change from 52-week low	14.05%
Change from all-time high	-61.39%
Change from all-time low	12.7%
Change from open	-0.47%
Day's gap	2.66%
Dollar volume	CAD 239,519
High price	CAD 4.24
Low price	CAD 4.17
Monthly RSI	28.69
Open price	CAD 4.24
Position in 52-week range	71.43%
Previous close	CAD 4.13
Price vs 150-day SMA	-8.97%
Price vs 20-day SMA	0.41%
Price vs 200-day SMA	-10.4%
Price vs 50-day SMA	-5.57%
Relative volume	1.63
RSI	45.17
Sharpe ratio	-0.48
Sortino ratio	-0.53
Volume	56.8K
Weekly RSI	38.47
YTD price change	-20.42%
YTD total return	-20.42%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.2B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.14%
Shares held by insiders	0.02%
Shares held by institutions	27.52%

Deeper analysis on NEO/NVON

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NEO/NVON report

Is a complete NEO/NVON research report available?

No complete published report is available for neo/NVON (NEO/NVON) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NEO/NVON (NEO/NVON)

Price

Financial snapshot

Fair-value bridge

Latest news · NEO/NVON

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NEO/NVON indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NEO/NVON

Frequently asked questions